http: //dx.doi.org/10.1289/ehp.1408629 Two articles in the March 2014 issue of EHP were of particular interest to exposure scien tists and phthalate researchers. The news article by Nicole (2014) emphasized the importance of the vaginal epithelium as an exposure route for chemicals in per sonal care products and the general lack of research on this exposure route. However, the article did not mention adult toys as a pos sible source of exposure. Adult toys are made from a variety of plastics, including polyvinyl chloride, and they may contain phthalates, some of which are associated with develop mental effects in males following in utero exposure in both animal and epidemiological studies. One report has suggested that certain combina tions of vehicle (personal lubricant) and product may result in high phthalate exposures (Nilsson et al. 2006) .
In their article, Zota et al. (2014) revealed that phthalate exposures in the United States are beginning to change after remaining relatively stable for a decade. The authors reported that urinary metabo lite levels of certain phthalates associated with male develop mental effects, including di(2ethyl hexyl) phthalate (DEHP) and dinbutyl phthalate (DnBP), are decreasing while exposure to other phthalates, diisobutyl phthalate (DiBP) and diisononyl phthalate (DiNP), are increasing. The observed trend is something of a good news-bad news story. The good news is that exposures to DEHP and DBP are declining. The bad news is that exposure to DiBP and DiNP, which are associated with similar health effects, are increasing. However, DiNP is less potent as an anti androgen than the other phthalates. Furthermore, exposure to phthalate substi tutes (e.g., Schütze et al. 2014) , as well as unregulated phthalates such as DiBP, are likely to increase. In the future, biomonitor ing studies such as the National Health and Nutrition Examination Survey (NHANES) and the National Children's Study (NCS) may need to shift their focus to substitutes. Like phthalates, many of the phthalate sub stitutes (including citrates and adipates) are high production volume chemicals, with little adequate toxicological data, and humans are exposed from multiple sources. We agree that the downward trend in exposures to phthalates such as dinbutyl phthalate (DnBP) and di(2ethylhexyl) phthalate (DEHP) is encouraging, but the rising trend in other phthalates, such as diiso butyl phthalate (DiBP) and diiso nonyl phthalate (DiNP), is worrisome. Lioy et al.
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note that DiNP is less potent as an anti androgen than the other phthalates. However, its increasing presence in the U.S. general population warrants public health concern: The U.S. Environmental Protection Agency (EPA) has expressed concern about DiNP's use [Phthalates Action Plan (U.S. EPA 2012)]; DiNP was added to California's Proposition 65 List of Potential Carcinogens in 2013 (California Office of Environmental Health Hazard Assessment 2014); and it can act cumulatively with other phthalates to affect male reproductive end points (National Research Council 2008) . Given the toxicologi cal evidence of potential harm, further study on its adverse health effects in epidemiologic studies is warranted.
Lioy et al. also comment on the impor tance of studying phthalate substitutes. We agree that it is important for NHANES (National Health and Nutrition Examination Survey) and other large environmental health studies to evaluate the presence of potential "substitute" chemicals not only of phthalates but also of other environmen tal chemicals to provide the best human exposure information. In fact, for the most recent NHANES survey (2011) (2012) , scien tists at the Centers for Disease Control and Prevention are beginning to release populationlevel data for the urinary metabo lite of 1,2cyclohexane dicarboxylic acid diiso nonyl ester (DINCH), a non phthalate plasticizer that is used as a replacement for some of the highmolecularweight phthalates (Centers for Disease Control and Prevention 2013). Indeed, biomonitoring data are extremely valuable for under standing popula tion exposures to high production volume chemicals and helping to prioritize chemicals of concern. However, NHANES records only the actions of the past. To fully characterize public health risks of chemicals and develop effective exposurereduction strategies, we need greater disclosure from manufacturers on chemical ingredients in consumer and other products; more complete data from the U.S. EPA on chemical production and use; and data to evaluate potential health hazards from these chemicals. With this information, we can make informed decisions about the use of chemicals in the market place, limit those that pose a risk to the population, and improve the public's health.
